Landscapes / Companies
CARsgen Therapeutics Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
1 in Phase 1
Drugs
4
in active trials · 8 in all
Trials
6 active
10 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Pancreatic Cancer, Gastric Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 15 Jun 2027Phase 1/2 trial completes | |||
| Next date | 15 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Multiple Myeloma, Primary Plasma Cell Leukemia | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Multiple Myeloma | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | HCC | ||||
| Open drug page | |||||
About
- No active trial
- AB011, CAR-BCMA T Cells, CAR-CD19 T Cells, CAR-GPC3 T Cells
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021